Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CG53135

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Goals of workThe objective of this study was to evaluate the safety and tolerability of velafermin in patients at risk of… Expand
  • table 1
  • table 2
  • table 4
  • table 3
Is this relevant?
2006
2006
6537 Background: Oral mucositis (OM) is a commonly occurring side effect of high-dose chemotherapy (HDCT) in patients (pts… Expand
Is this relevant?
2005
2005
The aim was to evaluate the radioprotective properties of recombinant human fibroblast growth factor 20 (FGF-20; CG53135-05) in… Expand
Is this relevant?
2005
2005
Oral mucositis (OM) is a treatment-limiting condition associated with myelosupressive chemotherapy and radiation therapy. The… Expand
Is this relevant?
2004
2004
6656 Background: Mucositis is a painful side effect of many transplant conditioning regimens. A new class of drugs in the… Expand
Is this relevant?
2004
2004
Oral mucositis (OM) is a common complication in cancer patients receiving chemotherapy (CT). OM is characterized by damage to the… Expand
Is this relevant?
2003
2003
PURPOSE The purpose of this study was to evaluate the activity of CG53135 (FGF-20), a protein with in vitro mitogenic activity on… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
Purpose: The purpose of this study was to evaluate the activity of CG53135 (FGF-20), a protein with in vitro mitogenic activity… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?